These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6409486)
41. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. Dabaghi SF; Kamat SG; Payne J; Marks GF; Roberts R; Schafer AI; Kleiman NS Am J Cardiol; 1994 Oct; 74(7):720-3. PubMed ID: 7942533 [TBL] [Abstract][Full Text] [Related]
42. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects. Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329 [TBL] [Abstract][Full Text] [Related]
43. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects. Rao AK; Willis J; Holmsen H J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260 [TBL] [Abstract][Full Text] [Related]
44. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets. Vincent JE; Zijlstra FJ; van Vliet H Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279 [No Abstract] [Full Text] [Related]
45. Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of cyclooxygenase activity. Hirakata H; Ushikubi F; Toda H; Nakamura K; Sai S; Urabe N; Hatano Y; Narumiya S; Mori K Anesthesiology; 1996 Dec; 85(6):1447-53. PubMed ID: 8968193 [TBL] [Abstract][Full Text] [Related]
46. A monoclonal anti-thromboxane B2 antibody. Reinke M; Brune K FEBS Lett; 1988 May; 232(1):46-50. PubMed ID: 3130275 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384 [TBL] [Abstract][Full Text] [Related]
48. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
49. RCS from human platelets: is it only thromboxane? Smith EF; Rücker W; Schrör K Eur J Pharmacol; 1983 Nov; 95(1-2):121-4. PubMed ID: 6667711 [TBL] [Abstract][Full Text] [Related]
50. Arachidonate induced aggregation of rat platelets may not require prostaglandin endoperoxides or thromboxane A2. Nishizawa EE; Williams DJ; Connell CL Thromb Res; 1983 May; 30(3):289-96. PubMed ID: 6868025 [TBL] [Abstract][Full Text] [Related]
51. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha. Vinge E; Corell T; Andersson KE Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029 [TBL] [Abstract][Full Text] [Related]
52. Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat. Vargaftig BB J Pharm Pharmacol; 1978 Feb; 30(2):101-4. PubMed ID: 24092 [TBL] [Abstract][Full Text] [Related]
53. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2]. Mazurov AB; Leĭtin VL; Repin VS Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262 [TBL] [Abstract][Full Text] [Related]
55. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets. Lindgren JA; Claesson HE; Kindahl H; Hammarström S Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886 [No Abstract] [Full Text] [Related]
56. Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. Lagarde M; Byron PA; Vargaftig BB; Dechavanne M Br J Haematol; 1978 Feb; 38(2):251-66. PubMed ID: 205238 [TBL] [Abstract][Full Text] [Related]
57. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate. Carter AJ; Heptinstall S Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261 [TBL] [Abstract][Full Text] [Related]
58. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. Stuart MJ; Gerrard JM; White JG N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406 [TBL] [Abstract][Full Text] [Related]
59. Long-term ultra-low-dose aspirin therapy and platelet function. Chetty N; Atkinson PM; Bradlow BA S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399 [TBL] [Abstract][Full Text] [Related]
60. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]